- 現金殖利率: 1.72%、總殖利率: 1.72%、5年平均現金配發率: 75.46%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 0.72 | -40.5 | 0.40 | -75.0 | 0.00 | 0 | 55.56 | -57.99 | 0.00 | 0 | 55.56 | -57.99 |
| 2022 (9) | 1.21 | -32.78 | 1.60 | 6.67 | 0.00 | 0 | 132.23 | 58.68 | 0.00 | 0 | 132.23 | 58.68 |
| 2021 (8) | 1.80 | 11.8 | 1.50 | 25.0 | 0.00 | 0 | 83.33 | 11.81 | 0.00 | 0 | 83.33 | 11.81 |
| 2020 (7) | 1.61 | -57.52 | 1.20 | 0.0 | 0.00 | 0 | 74.53 | 135.4 | 0.00 | 0 | 74.53 | 66.17 |
| 2019 (6) | 3.79 | -16.34 | 1.20 | 300.0 | 0.50 | -75.0 | 31.66 | 378.1 | 13.19 | -70.12 | 44.85 | -11.66 |
| 2018 (5) | 4.53 | 50.5 | 0.30 | 50.0 | 2.00 | 100.0 | 6.62 | -0.33 | 44.15 | 32.89 | 50.77 | 27.35 |
| 2017 (4) | 3.01 | -0.99 | 0.20 | -90.0 | 1.00 | 0 | 6.64 | -89.9 | 33.22 | 0 | 39.87 | -39.4 |
| 2016 (3) | 3.04 | -48.65 | 2.00 | -23.08 | 0.00 | 0 | 65.79 | 49.8 | 0.00 | 0 | 65.79 | 49.8 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 0.00 | -100.0 | -100.0 | 0.01 | -96.88 | -95.65 | 0.72 | 0.0 | -40.98 |
| 23Q3 (19) | 0.23 | 64.29 | 15.0 | 0.32 | -11.11 | 39.13 | 0.72 | 46.94 | -18.18 |
| 23Q2 (18) | 0.14 | -60.0 | -60.0 | 0.36 | 260.0 | 89.47 | 0.49 | 40.0 | -27.94 |
| 23Q1 (17) | 0.35 | 6.06 | 6.06 | 0.10 | -56.52 | -70.59 | 0.35 | -71.31 | 6.06 |
| 22Q4 (16) | 0.33 | 65.0 | -47.62 | 0.23 | 0.0 | -67.14 | 1.22 | 38.64 | -32.22 |
| 22Q3 (15) | 0.20 | -42.86 | -28.57 | 0.23 | 21.05 | -23.33 | 0.88 | 29.41 | -24.79 |
| 22Q2 (14) | 0.35 | 6.06 | -39.66 | 0.19 | -44.12 | -63.46 | 0.68 | 106.06 | -22.73 |
| 22Q1 (13) | 0.33 | -47.62 | 10.0 | 0.34 | -51.43 | -10.53 | 0.33 | -81.67 | 10.0 |
| 21Q4 (12) | 0.63 | 125.0 | 1475.0 | 0.70 | 133.33 | 775.0 | 1.80 | 53.85 | 11.8 |
| 21Q3 (11) | 0.28 | -51.72 | 16.67 | 0.30 | -42.31 | 42.86 | 1.17 | 32.95 | -25.48 |
| 21Q2 (10) | 0.58 | 93.33 | -50.85 | 0.52 | 36.84 | -62.32 | 0.88 | 193.33 | -33.83 |
| 21Q1 (9) | 0.30 | 650.0 | 87.5 | 0.38 | 375.0 | 52.0 | 0.30 | -81.37 | 87.5 |
| 20Q4 (8) | 0.04 | -83.33 | -90.48 | 0.08 | -61.9 | -57.89 | 1.61 | 2.55 | -57.52 |
| 20Q3 (7) | 0.24 | -79.66 | -65.22 | 0.21 | -84.78 | -70.42 | 1.57 | 18.05 | -53.41 |
| 20Q2 (6) | 1.18 | 637.5 | -55.3 | 1.38 | 452.0 | -40.0 | 1.33 | 731.25 | -58.7 |
| 20Q1 (5) | 0.16 | -61.9 | -72.88 | 0.25 | 31.58 | -58.33 | 0.16 | -95.78 | -72.88 |
| 19Q4 (4) | 0.42 | -39.13 | 0.0 | 0.19 | -73.24 | 0.0 | 3.79 | 12.46 | 0.0 |
| 19Q3 (3) | 0.69 | -73.86 | 0.0 | 0.71 | -69.13 | 0.0 | 3.37 | 4.66 | 0.0 |
| 19Q2 (2) | 2.64 | 347.46 | 0.0 | 2.30 | 283.33 | 0.0 | 3.22 | 445.76 | 0.0 |
| 19Q1 (1) | 0.59 | 0.0 | 0.0 | 0.60 | 0.0 | 0.0 | 0.59 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 3.91 | 63.03 | -25.42 | 10.46 | -11.43 | 10.46 | N/A | - | ||
| 2024/2 | 2.4 | -42.11 | -15.31 | 6.55 | -0.24 | 11.65 | N/A | - | ||
| 2024/1 | 4.15 | -18.72 | 11.21 | 4.15 | 11.21 | 12.42 | N/A | - | ||
| 2023/12 | 5.1 | 60.93 | -5.56 | 48.41 | -13.93 | 11.67 | 0.73 | - | ||
| 2023/11 | 3.17 | -6.76 | -27.24 | 43.31 | -14.82 | 10.97 | 0.78 | - | ||
| 2023/10 | 3.4 | -22.62 | -19.61 | 40.14 | -13.65 | 11.72 | 0.73 | - | ||
| 2023/9 | 4.4 | 12.0 | -39.68 | 36.74 | -13.06 | 11.81 | 0.76 | - | ||
| 2023/8 | 3.92 | 12.55 | -0.83 | 32.34 | -7.51 | 11.73 | 0.76 | - | ||
| 2023/7 | 3.49 | -19.21 | 0.16 | 28.42 | -8.36 | 11.86 | 0.76 | - | ||
| 2023/6 | 4.32 | 6.3 | -31.44 | 24.93 | -9.44 | 13.12 | 0.67 | - | ||
| 2023/5 | 4.06 | -14.42 | 25.79 | 20.62 | -2.92 | 14.05 | 0.62 | - | ||
| 2023/4 | 4.74 | -9.63 | 6.62 | 16.56 | -8.07 | 12.83 | 0.68 | - | ||
| 2023/3 | 5.25 | 85.14 | -12.11 | 11.81 | -12.89 | 11.81 | 0.75 | - | ||
| 2023/2 | 2.84 | -23.97 | 9.88 | 6.56 | -13.51 | 11.97 | 0.74 | - | ||
| 2023/1 | 3.73 | -30.98 | -25.56 | 3.73 | -25.56 | 13.49 | 0.66 | - | ||
| 2022/12 | 5.4 | 23.98 | 16.75 | 56.25 | 9.31 | 13.99 | 0.64 | - | ||
| 2022/11 | 4.36 | 3.01 | 0.74 | 50.85 | 8.57 | 15.88 | 0.57 | - | ||
| 2022/10 | 4.23 | -41.94 | 6.51 | 46.49 | 9.37 | 15.47 | 0.58 | - | ||
| 2022/9 | 7.29 | 84.15 | 30.49 | 42.26 | 9.66 | 14.72 | 0.61 | - | ||
| 2022/8 | 3.96 | 13.68 | 7.08 | 34.97 | 6.13 | 13.73 | 0.66 | - | ||
| 2022/7 | 3.48 | -44.7 | 4.81 | 31.01 | 6.01 | 13.0 | 0.7 | - | ||
| 2022/6 | 6.29 | 95.05 | -3.58 | 27.53 | 6.17 | 13.97 | 0.56 | - | ||
| 2022/5 | 3.23 | -27.46 | -18.38 | 21.24 | 9.45 | 13.65 | 0.58 | - | ||
| 2022/4 | 4.45 | -25.51 | 4.74 | 18.01 | 16.57 | 13.0 | 0.6 | - | ||
| 2022/3 | 5.97 | 131.5 | 42.88 | 13.56 | 21.84 | 13.56 | 0.57 | - | ||
| 2022/2 | 2.58 | -48.5 | -17.69 | 7.59 | 9.19 | 12.22 | 0.63 | - | ||
| 2022/1 | 5.01 | 8.25 | 31.28 | 5.01 | 31.28 | 13.96 | 0.55 | - | ||
| 2021/12 | 4.63 | 6.97 | -17.05 | 51.46 | 9.92 | 12.93 | 0.6 | - | ||
| 2021/11 | 4.33 | 8.91 | 3.49 | 46.83 | 13.56 | 13.88 | 0.56 | - | ||
| 2021/10 | 3.97 | -28.87 | -12.65 | 42.5 | 14.7 | 13.25 | 0.58 | - | ||
| 2021/9 | 5.58 | 51.11 | 43.01 | 38.53 | 18.53 | 12.6 | 0.44 | - | ||
| 2021/8 | 3.7 | 11.28 | 9.84 | 32.95 | 15.19 | 13.54 | 0.41 | - | ||
| 2021/7 | 3.32 | -49.13 | 2.23 | 29.25 | 15.9 | 13.8 | 0.4 | - | ||
| 2021/6 | 6.53 | 65.1 | -7.69 | 25.93 | 17.92 | 14.73 | 0.38 | - | ||
| 2021/5 | 3.95 | -6.9 | 25.58 | 19.4 | 30.06 | 12.38 | 0.46 | - | ||
| 2021/4 | 4.25 | 1.6 | 28.4 | 15.45 | 31.26 | 11.56 | 0.49 | - | ||
| 2021/3 | 4.18 | 33.35 | 46.31 | 11.13 | 31.53 | 11.13 | 0.53 | - | ||
| 2021/2 | 3.13 | -17.85 | 42.43 | 6.95 | 23.99 | 12.53 | 0.47 | - | ||
| 2021/1 | 3.82 | -31.6 | 12.08 | 3.82 | 12.08 | 13.58 | 0.43 | - | ||
| 2020/12 | 5.58 | 33.47 | 40.6 | 46.81 | 0.18 | 14.31 | 0.41 | - | ||
| 2020/11 | 4.18 | -8.07 | 16.86 | 41.23 | -3.56 | 12.63 | 0.47 | - | ||
| 2020/10 | 4.55 | 16.46 | 15.56 | 37.05 | -5.42 | 11.82 | 0.5 | - | ||
| 2020/9 | 3.9 | 16.06 | 5.79 | 32.51 | -7.76 | 10.52 | 0.6 | - | ||
| 2020/8 | 3.36 | 3.56 | -11.62 | 28.6 | -9.35 | 13.68 | 0.46 | - | ||
| 2020/7 | 3.25 | -54.07 | -1.5 | 25.24 | -9.04 | 13.47 | 0.47 | - | ||
| 2020/6 | 7.07 | 124.62 | 53.67 | 21.99 | -10.06 | 13.53 | 0.33 | 2020年6月單月營收較去年同期大幅增加係因認列放射腫瘤機台銷售收入。 | ||
| 2020/5 | 3.15 | -4.81 | -33.13 | 14.92 | -24.83 | 9.31 | 0.47 | - | ||
| 2020/4 | 3.31 | 15.77 | -23.33 | 11.77 | -22.25 | 8.37 | 0.53 | - | ||
| 2020/3 | 2.86 | 29.82 | -23.5 | 8.46 | -21.83 | 8.46 | 0.46 | - | ||
| 2020/2 | 2.2 | -35.36 | -34.29 | 5.61 | -20.94 | 9.57 | 0.41 | - | ||
| 2020/1 | 3.4 | -14.19 | -8.99 | 3.4 | -8.99 | 10.95 | 0.36 | - | ||
| 2019/12 | 3.97 | 10.93 | 17.97 | 46.72 | 19.0 | 11.48 | 0.39 | - | ||
| 2019/11 | 3.58 | -9.09 | 12.18 | 42.76 | 19.1 | 11.2 | 0.4 | - | ||
| 2019/10 | 3.93 | 6.61 | 14.32 | 39.18 | 19.77 | 11.43 | 0.39 | - | ||
| 2019/9 | 3.69 | -3.04 | -1.62 | 35.25 | 20.42 | 10.79 | 0.53 | - | ||
| 2019/8 | 3.81 | 15.43 | 0.86 | 31.55 | 23.66 | 11.71 | 0.49 | - | ||
| 2019/7 | 3.3 | -28.34 | 9.92 | 27.75 | 27.61 | 12.61 | 0.46 | - | ||
| 2019/6 | 4.6 | -2.25 | 22.32 | 24.45 | 30.45 | 13.63 | 0.28 | - | ||
| 2019/5 | 4.71 | 9.13 | 47.03 | 19.85 | 32.49 | 0.0 | N/A | - | ||
| 2019/4 | 4.31 | 15.51 | 44.76 | 15.14 | 28.53 | 0.0 | N/A | - |
